IP-rich Japanese companies may face new competition issues in Europe: CJEU's decision in AstraZeneca *

European Union, Japan - March 25 2013
Japanese companies that enjoy a dominant position in a particular market in Europe are likely to be aware that they are subject to high standards of…

Co-authors: Gavin Margetson, Naomi Lisney, Daniel Preston.

---

EU patent package agreed and approved *

European Union - January 28 2013
The EU unitary patent ("UP") system is marching closer to reality following a recent flurry of activity. On 11 December 2012, the European Parliament…

Co-authors: Gavin Margetson, Naomi Lisney, Graeme Preston.

---

The UK government proposes better protection for pharmaceutical companies conducting clinical trials *

European Union, United Kingdom - November 27 2012
As many Japanese companies in the healthcare and veterinary fields may have experienced or be aware, obtaining regulatory approval to market a drug in Europe can be time-consuming and often challenging.

Co-authors: Gavin Margetson, Naomi Lisney, Graeme Preston.

---

Further update on the EU patent package *

European Union - September 24 2012
For many decades, the patent system in Europe has been under review.

Co-authors: Gavin Margetson, Naomi Lisney, Graeme Preston.

---

Network sharing: benefits and legal considerations *

Global, United Kingdom - August 27 2012
Japanese and other global mobile network operators are increasingly facing the need to expand and upgrade their existing networks, despite the often high costs in doing so.

Co-authors: Gavin Margetson, Graeme Preston, Nicholas Fawcett.

---